Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2015 1
2018 1
2019 5
2020 6
2021 8
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.
Chien KS, Kim K, Nogueras-Gonzalez GM, Borthakur G, Naqvi K, Daver NG, Montalban-Bravo G, Cortes JE, DiNardo CD, Jabbour E, Alvarado Y, Andreeff M, Bose P, Jain N, Kadia TM, Huang X, Sheppard KB, Klingner-Winton C, Pierce SA, Dong XQ, Soltysiak KA, Kantarjian HM, Garcia-Manero G. Chien KS, et al. Among authors: soltysiak ka. Br J Haematol. 2021 Nov;195(3):378-387. doi: 10.1111/bjh.17689. Epub 2021 Aug 2. Br J Haematol. 2021. PMID: 34340254 Clinical Trial.
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K, Kanagal-Shamanna R, Montalban-Bravo G, Assi R, Jabbour E, Ravandi F, Kadia T, Pierce S, Takahashi K, Nogueras Gonzalez G, Patel K, Soltysiak KA, Cortes J, Kantarjian HM, Garcia-Manero G. Sasaki K, et al. Among authors: soltysiak ka. Cancer. 2020 Feb 15;126(4):765-774. doi: 10.1002/cncr.32566. Epub 2019 Nov 19. Cancer. 2020. PMID: 31742675 Free article.
The role of TGFβ in hematopoiesis and myeloid disorders.
Bataller A, Montalban-Bravo G, Soltysiak KA, Garcia-Manero G. Bataller A, et al. Among authors: soltysiak ka. Leukemia. 2019 May;33(5):1076-1089. doi: 10.1038/s41375-019-0420-1. Epub 2019 Feb 28. Leukemia. 2019. PMID: 30816330 Review.
Hematopoiesis under telomere attrition at the single-cell resolution.
Thongon N, Ma F, Santoni A, Marchesini M, Fiorini E, Rose A, Adema V, Ganan-Gomez I, Groarke EM, Gutierrez-Rodrigues F, Chen S, Lockyer P, Schneider S, Bueso-Ramos C, Montalban-Bravo G, Class CA, Soltysiak KA, Pellegrini M, Sahin E, Bertuch AA, DiNardo CD, Garcia-Manero G, Young NS, Dwyer K, Colla S. Thongon N, et al. Among authors: soltysiak ka. Nat Commun. 2021 Nov 25;12(1):6850. doi: 10.1038/s41467-021-27206-7. Nat Commun. 2021. PMID: 34824242 Free PMC article.
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.
Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Masarova L, Naqvi K, Jabbour E, DiNardo CD, Takahashi K, Konopleva M, Pemmaraju N, Kadia TM, Ravandi F, Daver N, Borthakur G, Estrov Z, Khoury JD, Loghavi S, Soltysiak KA, Pierce S, Bueso-Ramos C, Patel KP, Verstovsek S, Kantarjian HM, Bose P, Garcia-Manero G. Montalban-Bravo G, et al. Among authors: soltysiak ka. Cancer. 2021 Sep 1;127(17):3113-3124. doi: 10.1002/cncr.33622. Epub 2021 Apr 29. Cancer. 2021. PMID: 33914911
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
Sasaki K, Montalban-Bravo G, Kanagal-Shamanna R, Jabbour E, Ravandi F, Kadia T, Daver N, Pemmaraju N, Konopleva M, Borthakur G, Takahashi K, Patel K, Soltysiak KA, Chien KS, Sakurai K, Pierce S, Kantarjian HM, Garcia-Manero G. Sasaki K, et al. Among authors: soltysiak ka. Am J Hematol. 2020 Dec;95(12):E326-E329. doi: 10.1002/ajh.25991. Epub 2020 Oct 2. Am J Hematol. 2020. PMID: 32886803 Free article. No abstract available.
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.
Kanagal-Shamanna R, Montalban-Bravo G, Katsonis P, Sasaki K, Class CA, Jabbour E, Sallman D, Hunter AM, Benton C, Chien KS, Luthra R, Bueso-Ramos CE, Kadia T, Andreeff M, Komrokji RS, Al Ali NH, Short N, Daver N, Routbort MJ, Khoury JD, Patel K, Ganan-Gomez I, Wei Y, Borthakur G, Ravandi F, Do KA, Soltysiak KA, Lichtarge O, Medeiros LJ, Kantarjian H, Garcia-Manero G. Kanagal-Shamanna R, et al. Among authors: soltysiak ka. Blood Cancer J. 2021 Mar 6;11(3):52. doi: 10.1038/s41408-021-00446-y. Blood Cancer J. 2021. PMID: 33677472 Free PMC article. No abstract available.
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
Kanagal-Shamanna R, Montalban-Bravo G, Sasaki K, Darbaniyan F, Jabbour E, Bueso-Ramos C, Wei Y, Chien K, Kadia T, Ravandi F, Borthakur G, Soltysiak KA, Routbort M, Patel K, Pierce S, Medeiros LJ, Kantarjian HM, Garcia-Manero G. Kanagal-Shamanna R, et al. Among authors: soltysiak ka. Cancer. 2021 Oct 1;127(19):3552-3565. doi: 10.1002/cncr.33745. Epub 2021 Jun 23. Cancer. 2021. PMID: 34161603
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia.
Montalban-Bravo G, Darbaniyan F, Kanagal-Shamanna R, Ganan-Gomez I, Class CA, Sasaki K, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien KS, Bueso-Ramos C, Do KA, Kantarjian H, Garcia-Manero G. Montalban-Bravo G, et al. Among authors: soltysiak ka. Leuk Res. 2021 Feb;101:106511. doi: 10.1016/j.leukres.2021.106511. Epub 2021 Jan 19. Leuk Res. 2021. PMID: 33517186
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome.
Morita K, Jabbour E, Ravandi F, Borthakur G, Khoury JD, Hu S, Garcia-Manero G, Wierda W, Issa G, Daver N, Pemmaraju N, Montalban-Bravo G, Soltysiak KA, Pierce S, Bueso-Ramos C, Cortes J, Sasaki K. Morita K, et al. Among authors: soltysiak ka. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):338-344. doi: 10.1016/j.clml.2020.12.025. Epub 2021 Jan 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33597098
23 results